VIKING THERAPEUTICS INC
VKTX·92686J106·US·Common Stock·Healthcare - Biotechnology-13D/G
VKTX (VIKING THERAPEUTICS INC) is held by 167 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($223.9M), FMR LLC ($196M), VANGUARD CAPITAL MANAGEMENT LLC ($163.1M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 93 funds bought VKTX.
167
Holders
Avg rating(31 Elite)
$2.1B
Total Value
53% (184)
Fund Consensus
93 buying - 81 selling
Who's Trading
InsiderAWAubuchon Neil WilliamBuy $150KMar 10, 2026
InsiderLBLian BrianSell $1.4MOct 28, 2025
InsiderMMMancini MariannaSell $216KOct 28, 2025
InsiderZGZANTE GREGSell $216KOct 28, 2025
InsiderRJRowland Charles A JrSell $2.1MOct 27, 2025
InsiderLBLian BrianSell $748KJul 3, 2025
13F: Insider & Congress:
Showing 1-20 of 184
1 / 10
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer